Windtree Therapeutics Investor Relations Material

Windtree Therapeutics Inc. is a U.S.-based biotechnology company focused on developing innovative therapies for acute cardiovascular and pulmonary conditions. The company’s pipeline includes drug candidates and technologies aimed at treating heart failure, acute respiratory distress syndrome (ARDS), and other serious cardiopulmonary diseases. Windtree’s research leverages expertise in both synthetic surfactants and precision pharmacology to address critical, unmet medical needs in hospital and critical care settings. The company is headquartered in Warrington, Pennsylvania, and its shares are listed on the Nasdaq.